C. van Booma-Frankfort

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial

J. Jacobs, G. A. van Albada-Kuipers, J. Bijlsma, 2000, Annals of the rheumatic diseases.

The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.

J. Jacobs, J. Bijlsma, G. A. Schellekens, 1999, Clinical and experimental rheumatology.

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

G. A. van Albada-Kuipers, J. Bijlsma, M. J. van der Veen, 1996, Annals of the rheumatic diseases.

Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy

J. Jacobs, G. A. van Albada-Kuipers, J. Bijlsma, 2006, Annals of the rheumatic diseases.

Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet

J. Jacobs, J. Bijlsma, P. Welsing, 2011, Annals of the rheumatic diseases.

Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study

M. Bakker, S. Linn-Rasker, E. Ton, 2011, Annals of the rheumatic diseases.